One of the serious blood disorders, beta thalassemia, can now be cured by a new gene therapy using the revolutionary gene-editing tool of CRISPR-Cas9 technology that is giving hope to hundreds of sufferers in England. The one-time therapy would ensure the faulty genes in their bone marrow are rectified. Trials have already shown more than …














